Reuters - Early data from a 4-year clinical trial show no increased risk of stroke in patients given Pfizer Inc’s lung drug Spiriva compared with placebo, the U.S. Food and Drug Administration said on Tuesday.
Herbal-Review.com
Independent honest reviews of most effective natural herbal supplements
Data show no stroke risk with Pfizer lung drug: FDA (Reuters)
[link]
The URI to TrackBack this entry is: http://herbal-review.com/2008/10/07/data-show-no-stroke-risk-with-pfizer-lung-drug-fda-reuters/trackback/
Leave a Reply
Please healthy :)
You must be logged in to post a comment.
|No results yet!
